Christopher BoffiExecutive Director, Advisory
Chris is an Executive Director in Perella Weinberg Partners’ advisory business. Chris has extensive experience in consumer segments with rapidly evolving regulatory environments, including reduced-harm nicotine, tobacco, cannabis, brewing and spirits.
Representative transactions in reduced-harm nicotine and tobacco include advising: Altria on several assignments, including its acquisition of a majority stake in on!, investment of a minority stake in JUUL, and acquisition of Nat Sherman; and the first lien creditors of Pyxus International during its Chapter 11 bankruptcy.
Representative transactions in cannabis include advising: Parallel on its merger with Ceres Acquisition Corp. (+ simultaneous $225 million PIPE capital raise) and acquisition of Windy City Cannabis; Altria on its investment in Cronos; and Cronos on its acquisition of Lord Jones.
Representative transactions in alcohol include advising: Altria on the sale of its 27% stake in SABMiller to ABI; City Brewing on its sale to Pabst Brewing Company; Castle Brands on its sale to Pernod Ricard; Heaven Hill on its acquisition of Deep Eddy Vodka; and Pabst Brewing Company on its sale to Eugene Kasper and TSG Consumer.
Chris has also advised other retail and consumer companies on a variety of M&A, shareholder activism and capital structure assignments. Representative transactions include advising: GameStop on its strategic review, sale of Spring Mobile to Prime Communications, cooperation agreement with activists Hestia Capital and Permit Capital, and exchange offer of outstanding senior notes; Kate Spade on its sale to Coach; Express on its takeover defense from Sycamore Partners; Coldwater Creek on its restructuring and sale of intellectual property to Sycamore Partners; and Henkel on its acquisition of Sun Products.
Chris received a Bachelor of Arts from University of Michigan in Behavioral Economics.